BRPI0520212A2 - métodos de geração de um vertebrado não humano transgênico, e de uma célula de vertebrado recombinante, célula de vertebrado em cultura, e, ácido nucleico - Google Patents

métodos de geração de um vertebrado não humano transgênico, e de uma célula de vertebrado recombinante, célula de vertebrado em cultura, e, ácido nucleico

Info

Publication number
BRPI0520212A2
BRPI0520212A2 BRPI0520212-4A BRPI0520212A BRPI0520212A2 BR PI0520212 A2 BRPI0520212 A2 BR PI0520212A2 BR PI0520212 A BRPI0520212 A BR PI0520212A BR PI0520212 A2 BRPI0520212 A2 BR PI0520212A2
Authority
BR
Brazil
Prior art keywords
vertebrate
methods
transgenic non
vertebrate cell
human
Prior art date
Application number
BRPI0520212-4A
Other languages
English (en)
Inventor
Tian Xu
Min Han
Yuan Zhuang
Xiaohui Wu
Sheng Ding
Gang Li
Original Assignee
Univ Fudan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Fudan filed Critical Univ Fudan
Publication of BRPI0520212A2 publication Critical patent/BRPI0520212A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

MéTODOS DE GERAçãO DE UM VERTEBRADO NãO HUMANO TRANSGêNICO, E DE UMA CéLULA DE VERTEBRADO RECOMBINANTE, CéLULA DE VERTEBRADO EM CULTURA, E, áCIDO NUCLEICO. A presente invenção refere-se a células de vertebrado transgênicas, incluindo mamíferos, cujos genomas compreendem um ou mais elementos do sistema transposon da família piggyBac. Os vertebrados não humanos transgênicos, incluindo mamíferos não humanos transgénicos, cujos genomas compreendem um ou mais elementos do sistema transposon da família piggyBac, são também providos. Os métodos de fazer e usar as células e animais da invenção, incluindo aplicações nos campos médico, veterinário e agrícola, são adicionalmente providos. A presente invenção também refere-se a kits utilizáveis para praticar estes métodos.
BRPI0520212-4A 2005-05-14 2005-05-14 métodos de geração de um vertebrado não humano transgênico, e de uma célula de vertebrado recombinante, célula de vertebrado em cultura, e, ácido nucleico BRPI0520212A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2005/000674 WO2006122442A1 (en) 2005-05-14 2005-05-14 Piggybac as a tool for genetic manipulation and analysis in vertebrates

Publications (1)

Publication Number Publication Date
BRPI0520212A2 true BRPI0520212A2 (pt) 2009-08-18

Family

ID=37430916

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520212-4A BRPI0520212A2 (pt) 2005-05-14 2005-05-14 métodos de geração de um vertebrado não humano transgênico, e de uma célula de vertebrado recombinante, célula de vertebrado em cultura, e, ácido nucleico

Country Status (11)

Country Link
US (1) US20100154070A1 (pt)
EP (1) EP1896578A4 (pt)
JP (1) JP2008545375A (pt)
CN (1) CN101297031B (pt)
AU (1) AU2005331864A1 (pt)
BR (1) BRPI0520212A2 (pt)
CA (1) CA2608481A1 (pt)
IL (1) IL187348A0 (pt)
MX (1) MX2007014139A (pt)
NO (1) NO20076465L (pt)
WO (1) WO2006122442A1 (pt)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10087463B2 (en) * 2000-10-31 2018-10-02 University Of Notre Dame Du Lac Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac
US20110047635A1 (en) * 2006-08-28 2011-02-24 University of Hawail Methods and compositions for transposon-mediated transgenesis
EP2113029A4 (en) * 2007-02-09 2010-06-02 Univ Utah Res Found IN VIVO GENERAL MUTAGENESIS
US20090042297A1 (en) * 2007-06-01 2009-02-12 George Jr Alfred L Piggybac transposon-based vectors and methods of nucleic acid integration
JP5588866B2 (ja) * 2007-08-10 2014-09-10 メダレックス エル．エル．シー． Ｈｃｏ３２およびｈｃｏ２７、ならびに関連実施例
EP2401367B1 (en) 2009-02-26 2016-11-30 Transposagen Biopharmaceuticals, Inc. Hyperactive piggybac transposases
US9445581B2 (en) 2012-03-28 2016-09-20 Kymab Limited Animal models and therapeutic molecules
NZ597481A (en) * 2009-07-08 2013-10-25 Kymab Ltd Animal models and therapeutic molecules
US20120204278A1 (en) 2009-07-08 2012-08-09 Kymab Limited Animal models and therapeutic molecules
CN101851637B (zh) * 2010-01-15 2011-12-14 中国农业科学院北京畜牧兽医研究所 一种制备同时表达多个基因的转基因动物的方法
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
US20130045492A1 (en) 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
KR102116296B1 (ko) 2010-02-08 2020-05-28 리제너론 파마슈티칼스 인코포레이티드 일반적인 경쇄 마우스
BR112014002713B1 (pt) 2011-08-05 2023-01-17 Regeneron Pharmaceuticals, Inc Métodos para produzir camundongos geneticamente modificados, uso dos referidos camundongos e uso de uma sequência de ácido nucleico produzida pelos referidos camundongos
CA2846319A1 (en) 2011-09-19 2013-03-28 Kymab Limited Antibodies, variable domains & chains tailored for human use
WO2013045916A1 (en) 2011-09-26 2013-04-04 Kymab Limited Chimaeric surrogate light chains (slc) comprising human vpreb
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
US10251377B2 (en) 2012-03-28 2019-04-09 Kymab Limited Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
CN102943092B (zh) * 2012-11-20 2014-12-10 西北农林科技大学 一种通用型PiggyBac转座子转基因载体及其制备方法
US9788534B2 (en) 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
US9783618B2 (en) 2013-05-01 2017-10-10 Kymab Limited Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
US11707056B2 (en) 2013-05-02 2023-07-25 Kymab Limited Animals, repertoires and methods
US9783593B2 (en) 2013-05-02 2017-10-10 Kymab Limited Antibodies, variable domains and chains tailored for human use
US20170159070A1 (en) * 2013-06-06 2017-06-08 Agency For Science, Technology And Research Transposon for genome manipulation
CA2919503C (en) 2013-07-12 2019-06-25 University Of South Alabama Minimal piggybac vectors for genome integration
CN105683365A (zh) 2013-10-01 2016-06-15 科马布有限公司 动物模型及治疗分子
CA2930315A1 (en) * 2013-11-18 2015-05-21 Yale University Compositions and methods of using transposons
US20150197759A1 (en) * 2014-01-14 2015-07-16 Lam Therapeutics, Inc. Mutagenesis methods
CA3124228C (en) 2014-03-21 2024-05-14 Regeneron Pharmaceuticals, Inc. Non-human animals that make single domain binding proteins
US10927384B2 (en) 2014-04-09 2021-02-23 Dna Twopointo Inc. DNA vectors, transposons and transposases for eukaryotic genome modification
WO2015157579A2 (en) 2014-04-09 2015-10-15 Dna2.0, Inc. Enhanced nucleic acid constructs for eukaryotic gene expression
CN107438622A (zh) 2015-03-19 2017-12-05 瑞泽恩制药公司 选择结合抗原的轻链可变区的非人动物
CN106521638A (zh) * 2015-09-09 2017-03-22 潘雨堃 一种基因突变大鼠资源库及其制备方法
CN106544359B (zh) * 2015-09-22 2019-07-19 复旦大学 Gpr45基因的用途
EP3359671B1 (en) 2015-10-08 2021-08-18 Dna Twopointo Inc. Dna vectors, transposons and transposases for eukaryotic genome modification
JP6956416B2 (ja) * 2015-12-14 2021-11-02 ゲノムフロンティア セラピューティクス，インコーポレイテッド トランスポゾン系、それを含むキット及びそれらの使用
US11299748B2 (en) * 2016-03-25 2022-04-12 GenomeFrontier Therapeutics, Inc. Kit for constructing transposon and use thereof
WO2018110374A1 (ja) * 2016-12-14 2018-06-21 国立大学法人信州大学 殺細胞効果を有するキメラ抗原受容体遺伝子改変リンパ球
JP7203367B2 (ja) * 2017-12-14 2023-01-16 公益財団法人実験動物中央研究所 哺乳動物細胞用遺伝子導入ベクター
WO2019219947A1 (en) * 2018-05-18 2019-11-21 Sorbonne Universite Molecular tools and methods for transgene integration and their transposition dependent expression
JP2021534798A (ja) * 2018-08-28 2021-12-16 フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー ゲノムを調節するための方法及び組成物
CN113348248A (zh) 2018-10-24 2021-09-03 思兰克斯有限公司 表达***、重组细胞及其用途
JP7418469B2 (ja) * 2019-04-08 2024-01-19 ディーエヌエー ツーポイントオー インク． アミエロイス由来のトランスポザーゼを用いた核酸コンストラクトの真核生物のゲノムへの転移
AU2020272668B2 (en) * 2019-04-08 2023-07-06 Dna Twopointo Inc. Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
CN111909986B (zh) * 2019-05-10 2024-03-26 潘雨堃 一种基因治疗安全评估与毒副作用预防的方法
JP2021016370A (ja) * 2019-07-23 2021-02-15 株式会社東芝 核酸導入キャリア、核酸導入キャリアセット、核酸導入組成物及び核酸導入方法
JP2021016371A (ja) * 2019-07-23 2021-02-15 株式会社東芝 Ｃａｒ−ｔ細胞の製造方法、核酸導入キャリア及びキット
KR20220140620A (ko) * 2020-02-19 2022-10-18 우시 바이올로직스 아일랜드 리미티드 강화된 발현 시스템 및 그 사용방법
CN113584083A (zh) 2020-04-30 2021-11-02 深圳市深研生物科技有限公司 用于逆转录病毒载体的生产细胞和包装细胞及其制备方法
CN111534542A (zh) * 2020-05-07 2020-08-14 西南大学 piggyBac转座子***介导的真核生物转基因细胞系及构建方法
WO2022012544A1 (zh) * 2020-07-13 2022-01-20 黄菁 对非人动物进行基因改造和构建免疫缺陷动物模型的方法
IL311333A (en) 2021-09-09 2024-05-01 Iovance Biotherapeutics Inc Processes for the production of TIL products using a strong PD-1 TALEN
WO2023147488A1 (en) 2022-01-28 2023-08-03 Iovance Biotherapeutics, Inc. Cytokine associated tumor infiltrating lymphocytes compositions and methods
WO2024112571A2 (en) 2022-11-21 2024-05-30 Iovance Biotherapeutics, Inc. Two-dimensional processes for the expansion of tumor infiltrating lymphocytes and therapies therefrom
WO2024118836A1 (en) 2022-11-30 2024-06-06 Iovance Biotherapeutics, Inc. Processes for production of tumor infiltrating lymphocytes with shortened rep step

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218185B1 (en) * 1996-04-19 2001-04-17 The United States Of America As Represented By The Secretary Of Agriculture Piggybac transposon-based genetic transformation system for insects
US20030150007A1 (en) * 2000-03-21 2003-08-07 Charalambos Savakis Method of generating transgenic organisms using transposons
US6962810B2 (en) * 2000-10-31 2005-11-08 University Of Notre Dame Du Lac Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac
WO2003056912A2 (en) * 2002-01-09 2003-07-17 Minos Biosystems Limited Inducible transposition in transgenic organism using transposon vector
CN1234871C (zh) * 2003-03-27 2006-01-04 成都天创生物科技有限责任公司 一种解毒酶基因在家蚕中稳定表达***的构建方法

Also Published As

Publication number Publication date
US20100154070A1 (en) 2010-06-17
WO2006122442A1 (en) 2006-11-23
CN101297031B (zh) 2013-06-05
AU2005331864A1 (en) 2006-11-23
IL187348A0 (en) 2008-04-13
MX2007014139A (es) 2008-10-09
EP1896578A1 (en) 2008-03-12
CN101297031A (zh) 2008-10-29
JP2008545375A (ja) 2008-12-18
NO20076465L (no) 2008-02-04
EP1896578A4 (en) 2008-11-05
CA2608481A1 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
BRPI0520212A2 (pt) métodos de geração de um vertebrado não humano transgênico, e de uma célula de vertebrado recombinante, célula de vertebrado em cultura, e, ácido nucleico
Ding et al. Inheritance and establishment of gut microbiota in chickens
BR112015002280A2 (pt) produção de gado resistente a vfa por substituição de alelo
AU2019264610A1 (en) Genetically modified animals and methods for making the same
CO6511231A2 (es) Estabilización de probióticos
García-Martínez et al. Glutathione ethyl ester protects in vitro-maturing bovine oocytes against oxidative stress induced by subsequent vitrification/warming
de Paula et al. Energy, ageing, fidelity and sex: oocyte mitochondrial DNA as a protected genetic template
BR112016002385A2 (pt) animal não humano, célula, tecido ou embrião, vetor de alvejamento, constructo de vetor de alvejamento, e, métodos para produzir um animal não humano e para modificar um lócus de incrna em uma célula pluripotente
BR112015029904A2 (pt) animais geneticamente estéreis
TR201806812T4 (tr) Rna-yönlendirmeli hedef dna modifikasyonu için ve rna-yönlendirmeli transkripsiyon modifikasyonu için yöntemler ve bileşimler.
BR112015009589A2 (pt) processos de produção de um animal de produção não humano, animal de produção geneticamente modificado não humano, organismo in vitro não humano escolhido do grupo que consiste em uma célula ou um animal blastocisto, o organismo in vitro, processo de produção de uma célula de animal de produção geneticamente modificado não humano, animal de produção não humano e método de produção de um animal de produção geneticamente modificado não humano
BR112017010547A2 (pt) métodos para produção de uma modificação bialélica, modificação de um genoma dentro de uma célula, produção de uma geração f0 de um animal não humano e identificação de uma inserção de um inserto de ácido nucleico.
BR112016013400A2 (pt) métodos para modificar um genoma e para produzir um camundongo
BRPI0606363A2 (pt) método para o isolamento e/ou a purificação de ácidos nucleicos ácido nucleico, e, método para a imobilização de ácidos nucleicos em uma matriz
Tian et al. Melatonin promotes the in vitro development of microinjected pronuclear mouse embryos via its anti-oxidative and anti-apoptotic effects
BR112012000942B8 (pt) processos para a produção de poliovírus, e para produzir uma vacina contra pólio
CA2932580A1 (en) Methods and compositions for generation of developmentally-incompetent eggs in recipients of nuclear genetic transfer
AR078899A1 (es) Anticuerpo anti linfopoyetina estromal timica (anti-tslp) modificado por tecnicas de ingenieria genetica
BR122019022434B8 (pt) método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular
MA32536B1 (fr) Composes organiques
EA200701427A1 (ru) Композиция клещей, её применение, способ разведения хищного клеща - фитосейида, система для разведения указанного хищного клеща - фитосейида и способы биологического контроля вредителей в культуре
BR112013005136A8 (pt) Compostos e composições nematicidas, bem como métodos para controlar pragas de nematódeo
BR112013018751A2 (pt) método de cultura de célula animal
Ci et al. Programming and inheritance of parental DNA methylomes in vertebrates
BR112013006043A2 (pt) gene-alvo para controle de nematoides fitoparasitas e uso dos mesmos.

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO EM SUA FORMA AUTENTICADA; OU SEGUNDO PARECER DA PROCURADORIA NO 074/93, DEVE CONSTAR UMA DECLARACAO DE VERACIDADE, A QUAL DEVE SER ASSINADA POR UMA PESSOA DEVIDAMENTE AUTORIZADA A REPRESENTAR O INTERESSADO, DEVENDO A MESMA CONSTAR NO INSTRUMENTO DE PROCURACAO, OU NO SEU SUBSTABELECIMENTO.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.